These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3149337)

  • 1. [Differential diagnosis of non-A, non-B hepatitis and drug-induced hepatopathy].
    Kiyosawa K; Yoshizawa K; Sodeyama T; Furuta S
    Nihon Rinsho; 1988 Dec; 46(12):2645-51. PubMed ID: 3149337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
    Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
    Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
    [No Abstract]   [Full Text] [Related]  

  • 3. [2' 5'-oligoadenylate synthetase (2-5AS)].
    Kaneko S; Sakai A
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():812-4. PubMed ID: 15658457
    [No Abstract]   [Full Text] [Related]  

  • 4. [2-5 Oligoadenylate synthetase].
    Koura T; Kato Y; Unoura M
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():202-5. PubMed ID: 8753217
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
    Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases.
    Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN
    Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis.
    Türktaş H; Unsal M; Tülek N; Orüç O
    Tuber Lung Dis; 1994 Feb; 75(1):58-60. PubMed ID: 8161767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-A, non-B hepatitis].
    Müller R
    Internist (Berl); 1985 Oct; 26(10):602-6. PubMed ID: 3935595
    [No Abstract]   [Full Text] [Related]  

  • 9. Epstein Barr virus-induced hepatitis associated with methotrexate treatment.
    Lapalus MG; Hot A; Fontana A; Guillaud O; Miossec P; Scoazec JY; Dumortier J
    J Clin Gastroenterol; 2008 Feb; 42(2):217-9. PubMed ID: 18209599
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic classification of increased liver enzymes].
    Fengler JD; Baumgarten R
    Z Arztl Fortbild (Jena); 1991 May; 85(9):440-2. PubMed ID: 1853632
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral versus drug hepatitis.
    Davis JS
    N Engl J Med; 1966 Apr; 274(14):803-4; author reply 804. PubMed ID: 17929370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxic hepatitis due to ecstasy administration: report of a possible case and literature review].
    Deltenre P; Henrion J; Jacques JM; Schapira M; Ghilain JM; Maisin JM; Heller FR
    Acta Gastroenterol Belg; 1994; 57(5-6):341-5. PubMed ID: 7709705
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells from patients with fulminant hepatitis.
    Nishino S; Ohnishi H; Muto Y; Moriwaki H; Sakai T; Sugihara J; Saitoh K
    Gastroenterol Jpn; 1989 Jun; 24(3):337. PubMed ID: 2744346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of toxic and drug-induced hepatocellular damage in patients treated in viral hepatitis units].
    Tolwińska I
    Pol Tyg Lek; 1977 Sep; 32(37):1425-8. PubMed ID: 905188
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-specific immune response in acute viral hepatitis: studies from serum 2,5-oligoadenylate synthetase activity and serum and histochemical changes in beta 2 microglobulin].
    Suzuki H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1508-17. PubMed ID: 3054207
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential diagnosis of alcholic and viral affections of the liver].
    Mukhin AS; Semendiaeva ME; Blinkov IL; Vinogradova LG
    Sov Med; 1977 May; (5):7-13. PubMed ID: 877751
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential diagnosis of various liver diseases in children with acute leukemia].
    Vaganov PD; Makhonova LA; Ismailova MKh; Talalaev AG
    Pediatriia; 1978 Jul; (7):26-9. PubMed ID: 673606
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-A, non-B hepatitis.
    Fagan EA; Williams R
    Semin Liver Dis; 1984 Nov; 4(4):314-35. PubMed ID: 6441254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of drug-induced liver damage. Problems and conclusions from the viewpoint of the clinician].
    Wiese M; Haupt R
    Gastroenterol J; 1989; 49(3):129-33. PubMed ID: 2629782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of lipid metabolic indices for the differential diagnosis of acute viral and toxic-allergic hepatitis in tuberculosis patients].
    Brezhko VP
    Probl Tuberk; 1980 Aug; (8):46-8. PubMed ID: 7403049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.